SULFONAMIDAS HETEROCICLICAS INIBIDORAS DA PRODUCAO DE BETA-AMILOIDE

Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs thereof. Methods of using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer'...

Full description

Saved in:
Bibliographic Details
Main Authors DIAMANITIS, GEORGE, MOORE, WILLIAM JAY, STOCK, JOSEPH RAYMOND, KREFT, ANTHONY FRANK, WOLLER, KEVIN ROGER, CASEBIER, DAVID SCOTT, KURBRAK, DENNIS MICHAEL, DEREK CECIL COLE, KUTTERER, KRISTINA MARTHA
Format Patent
LanguagePortuguese
Published 31.10.2006
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs thereof. Methods of using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's disease and Down's syndrome are described.
Bibliography:Application Number: PT20010993277T